# Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

> **NCT00105534** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 685 (actual)

## Conditions studied

- Bacterial Conjunctivitis

## Interventions

- **DRUG:** AzaSite
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT00105534
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 685 (ACTUAL)
- **Last updated:** 2013-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00105534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00105534, "Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00105534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*